All lobbying filings
CARDINAL POINT PARTNERS
CARDINAL POINT PARTNERS filed a Q4 termination report for TONIX PHARMACEUTICALS, INC. on July 1, 2026, reporting no lobbying activity.
Lobbying for TONIX PHARMACEUTICALS, INC. · biotechnology company--pharmaceuticals development and manufacturing
Filing · LD-2 quarterly report
Q4 terminationNo activity
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jul 1, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Representation ended
Oct 31, 2025
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.